Douglas Badenoch helps us prepare for another CAMHS Around the Campfire session by exploring a recent twin study on the aetiology of shame and its association with adolescent depression and anxiety.
Follow #CAMHScampfire on Twitter at 5pm BST on Tuesday 20th July for an online journal club discussing this paper. Or sign up now to join the free webinar hosted by ACAMH.
[read the full story...]
Delia Ciobotaru reviews a recent randomised controlled trial on the neurocognitive effects of transcranial direct current stimulation in depression.
[read the full story...]
Dolly Sud appraises a recent data linkage study on the impact of schizophrenia genetic liability on the association between schizophrenia and physical illness.
[read the full story...]
Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.
[read the full story...]
Ben Janaway explores a recent review in JAMA Psychiatry on the emerging clinical neuroscience of Autism Spectrum Disorder.
[read the full story...]
Lucy Bowes explores a multi-polygenic score approach to identifying individual vulnerabilities associated with the risk of bullying, which suggests that depression, ADHD, risk taking, BMI and intelligence are independently associated with exposure to bullying.
[read the full story...]
Byron Creese writes a #LetsTalkMentalHealthII blog about a recent genome-wide meta-analysis which identifies new loci and functional pathways influencing Alzheimer’s disease risk.
[read the full story...]
Megan Skelton explores a study that uses polygenic scores in the context of longitudinal developmental data, to characterise developmental trajectories and the role of neuropsychiatric genetic risk variants in early-onset depression.
[read the full story...]
Douglas Levinson on a genome-wide meta-analysis of depression in 807,553 individuals, which identifies 102 independent variants relating to the genetics of depression.
[read the full story...]
Thalia Eley and Gerome Breen explore a new systematic meta-review of predictors of antidepressant treatment outcome in depression, which looks at clinical and demographic variables, but also biomarkers including both genetic and neuroimaging data.
[read the full story...]
